G&E Herbal Biotechnology Co., Ltd.(TW:4911)
NT$25.00-0.30 (-1.19%)
TW:4911
G&E Herbal Biotechnology Co., Ltd. financials statements
NT$25.00
At close:-0.30 (-1.19%)
G&E Herbal Biotechnology Co., Ltd. (4911) Income Statement
G&E Herbal Biotechnology Co., Ltd. Income Statement
Last quarter (Q2 2026), G&E Herbal Biotechnology Co., Ltd.'s total revenue was NT$34.44M, a decrease of 56.97% from the same quarter last year. In Q2, G&E Herbal Biotechnology Co., Ltd.'s net income was NT$7.88M. See G&E Herbal Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 309.13M | NT$ 249.03M | NT$ 181.44M | NT$ 64.61M | NT$ 24.57M | |
| NT$ 259.60M | NT$ 205.34M | NT$ 144.59M | NT$ 39.35M | NT$ 9.63M | |
| NT$ 107.30M | NT$ 85.70M | NT$ 63.90M | NT$ 33.87M | NT$ 29.18M | |
| Depreciation and Amortization | NT$ 10.61M | NT$ 10.38M | NT$ 9.33M | NT$ 9.40M | NT$ 9.34M |
| NT$ 162.91M | NT$ 135.15M | NT$ 99.84M | NT$ 16.63M | NT$ -10.22M | |
| NT$ 152.30M | NT$ 119.65M | NT$ 80.68M | NT$ 7.23M | NT$ -19.56M | |
| NT$ 6.09M | NT$ 5.08M | NT$ 9.82M | NT$ 1.74M | NT$ 1.34M | |
| NT$ 158.39M | NT$ 124.73M | NT$ 90.50M | NT$ 7.23M | NT$ -18.22M | |
| NT$ 139.20M | NT$ 102.06M | NT$ 72.40M | NT$ 7.38M | NT$ -19.88M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.18 | NT$ 1.73 | NT$ 1.23 | NT$ 0.13 | NT$ -0.34 |
| Diluted EPS | NT$ 2.18 | NT$ 1.73 | NT$ 1.23 | NT$ 0.13 | NT$ -0.34 |
| Weighted Average Shares Outstanding | 63.72M | 59.00M | 58.86M | 55.66M | 55.66M |
| Weighted Average Shares Outstanding (Diluted) | 63.86M | 59.08M | 58.86M | 55.66M | 55.66M |
Currency in TWD

